🇺🇸 FDA
Patent

US 6476037

L-arginine and phosphodiesterase (PDE) inhibitor synergism

expired A61KA61K31/195A61K31/52

Quick answer

US patent 6476037 (L-arginine and phosphodiesterase (PDE) inhibitor synergism) held by The Regents of the University of California expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K31/195, A61K31/52, A61K45/06, A61P